Report Thumbnail
Product Code QY0913415488VH1
Published Date 2026/7/9
English189 PagesGlobal

Global BCI and EEG Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2026-2032 ‐ MedicalDevice_MedTech Market


Report Thumbnail
Product Code QY0913415488VH1
Published Date 2026/7/9
English 189 PagesGlobal

Global BCI and EEG Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2026-2032 ‐ MedicalDevice_MedTech Market



Abstract


Summary

This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
The global market for BCI and EEG was estimated to be worth US$ 705 million in 2025 and is forecast to a readjusted size of US$ 1375.6 million by 2032 with a CAGR of 9.9% during the forecast period 2026-2032.
Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for BCI and EEG, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding BCI and EEG.
The BCI and EEG market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global BCI and EEG market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCI and EEG companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Medtronic
Natus Medical
Nihon Kohden
NeuroPace Inc
Mindmaze SA
G.TEC
BrainCo
InteraXon
Brain Products GmbH
EGI
Blackrock Microsystems LLC
Emotiv Inc
Micromed
ANT Neuro B.V
Compumedics Limited
NeuroSky, Inc.
Artinis Medical Systems BV
Cadwell
Advanced Brain Monitoring
NCC Medical
SYMTOP
Neuroelectrics
Segment by Type
Hardware
Software and Service
Segment by Application
Medical
Consumer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of BCI and EEG in global and regional level.
Chapter 3: Detailed analysis of BCI and EEG company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, BCI and EEG revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Table of Contents

  • 1 Study Coverage

    • 1.1 BCI and EEG Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global BCI and EEG Market Size Growth Rate by Type (2021 VS 2025 VS 2032)
      • 1.2.2 Hardware
      • 1.2.3 Software and Service
    • 1.3 Market by Application
      • 1.3.1 Global BCI and EEG Market Size Growth Rate by Application (2021 VS 2025 VS 2032)
      • 1.3.2 Medical
      • 1.3.3 Consumer
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered
  • 2 Executive Summary

    • 2.1 Global BCI and EEG Market Size Estimates and Forecasts
    • 2.2 BCI and EEG Market Size by Region: 2025 Versus 2032
      • 2.2.1 Global BCI and EEG Revenue by Region: 2021-2026
      • 2.2.2 Global BCI and EEG Revenue Forecast by Region (2027-2032)
      • 2.2.3 Global BCI and EEG Revenue Market Share by Region (2021-2032)
  • 3 Global BCI and EEG by Company

    • 3.1 Global BCI and EEG Revenue by Company (2021-2026)
    • 3.2 Global BCI and EEG Revenue Share by Company (2021-2026)
    • 3.3 Competitive Landscape
      • 3.3.1 Key BCI and EEG Companies around the World: Ranking by Revenue
      • 3.3.2 Global BCI and EEG Market Concentration Ratio (CR5 and HHI) & (2021-2026)
      • 3.3.3 Global BCI and EEG Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.4 Global BCI and EEG Companies Headquarters & Product Type
      • 3.4.1 BCI and EEG Companies Headquarters
      • 3.4.2 Global BCI and EEG Companies Product & Service
      • 3.4.3 Date of International Companies Enter into BCI and EEG Market
    • 3.5 Global BCI and EEG Mergers & Acquisitions, Expansion Plans
  • 4 Company Profiles

    • 4.1 Medtronic
      • 4.1.1 Medtronic Company Information
      • 4.1.2 Medtronic Description, Business Overview
      • 4.1.3 Medtronic BCI and EEG Products Offered
      • 4.1.4 Medtronic BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.1.5 Medtronic BCI and EEG Revenue by Product in 2025
      • 4.1.6 Medtronic BCI and EEG Revenue by Application in 2025
      • 4.1.7 Medtronic BCI and EEG Revenue by Geographic Area in 2025
      • 4.1.8 Medtronic Recent Developments
    • 4.2 Natus Medical
      • 4.2.1 Natus Medical Company Information
      • 4.2.2 Natus Medical Description, Business Overview
      • 4.2.3 Natus Medical BCI and EEG Products Offered
      • 4.2.4 Natus Medical BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.2.5 Natus Medical BCI and EEG Revenue by Product in 2025
      • 4.2.6 Natus Medical BCI and EEG Revenue by Application in 2025
      • 4.2.7 Natus Medical BCI and EEG Revenue by Geographic Area in 2025
      • 4.2.8 Natus Medical Recent Developments
    • 4.3 Nihon Kohden
      • 4.3.1 Nihon Kohden Company Information
      • 4.3.2 Nihon Kohden Description, Business Overview
      • 4.3.3 Nihon Kohden BCI and EEG Products Offered
      • 4.3.4 Nihon Kohden BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.3.5 Nihon Kohden BCI and EEG Revenue by Product in 2025
      • 4.3.6 Nihon Kohden BCI and EEG Revenue by Application in 2025
      • 4.3.7 Nihon Kohden BCI and EEG Revenue by Geographic Area in 2025
      • 4.3.8 Nihon Kohden Recent Developments
    • 4.4 NeuroPace Inc
      • 4.4.1 NeuroPace Inc Company Information
      • 4.4.2 NeuroPace Inc Description, Business Overview
      • 4.4.3 NeuroPace Inc BCI and EEG Products Offered
      • 4.4.4 NeuroPace Inc BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.4.5 NeuroPace Inc BCI and EEG Revenue by Product in 2025
      • 4.4.6 NeuroPace Inc BCI and EEG Revenue by Application in 2025
      • 4.4.7 NeuroPace Inc BCI and EEG Revenue by Geographic Area in 2025
      • 4.4.8 NeuroPace Inc Recent Developments
    • 4.5 Mindmaze SA
      • 4.5.1 Mindmaze SA Company Information
      • 4.5.2 Mindmaze SA Description, Business Overview
      • 4.5.3 Mindmaze SA BCI and EEG Products Offered
      • 4.5.4 Mindmaze SA BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.5.5 Mindmaze SA BCI and EEG Revenue by Product in 2025
      • 4.5.6 Mindmaze SA BCI and EEG Revenue by Application in 2025
      • 4.5.7 Mindmaze SA BCI and EEG Revenue by Geographic Area in 2025
      • 4.5.8 Mindmaze SA Recent Developments
    • 4.6 G.TEC
      • 4.6.1 G.TEC Company Information
      • 4.6.2 G.TEC Description, Business Overview
      • 4.6.3 G.TEC BCI and EEG Products Offered
      • 4.6.4 G.TEC BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.6.5 G.TEC BCI and EEG Revenue by Product in 2025
      • 4.6.6 G.TEC BCI and EEG Revenue by Application in 2025
      • 4.6.7 G.TEC BCI and EEG Revenue by Geographic Area in 2025
      • 4.6.8 G.TEC Recent Development
    • 4.7 BrainCo
      • 4.7.1 BrainCo Company Information
      • 4.7.2 BrainCo Description, Business Overview
      • 4.7.3 BrainCo BCI and EEG Products Offered
      • 4.7.4 BrainCo BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.7.5 BrainCo BCI and EEG Revenue by Product in 2025
      • 4.7.6 BrainCo BCI and EEG Revenue by Application in 2025
      • 4.7.7 BrainCo BCI and EEG Revenue by Geographic Area in 2025
      • 4.7.8 BrainCo Recent Development
    • 4.8 InteraXon
      • 4.8.1 InteraXon Company Information
      • 4.8.2 InteraXon Description, Business Overview
      • 4.8.3 InteraXon BCI and EEG Products Offered
      • 4.8.4 InteraXon BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.8.5 InteraXon BCI and EEG Revenue by Product in 2025
      • 4.8.6 InteraXon BCI and EEG Revenue by Application in 2025
      • 4.8.7 InteraXon BCI and EEG Revenue by Geographic Area in 2025
      • 4.8.8 InteraXon Recent Development
    • 4.9 Brain Products GmbH
      • 4.9.1 Brain Products GmbH Company Information
      • 4.9.2 Brain Products GmbH Description, Business Overview
      • 4.9.3 Brain Products GmbH BCI and EEG Products Offered
      • 4.9.4 Brain Products GmbH BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.9.5 Brain Products GmbH BCI and EEG Revenue by Product in 2025
      • 4.9.6 Brain Products GmbH BCI and EEG Revenue by Application in 2025
      • 4.9.7 Brain Products GmbH BCI and EEG Revenue by Geographic Area in 2025
      • 4.9.8 Brain Products GmbH Recent Development
    • 4.10 EGI
      • 4.10.1 EGI Company Information
      • 4.10.2 EGI Description, Business Overview
      • 4.10.3 EGI BCI and EEG Products Offered
      • 4.10.4 EGI BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.10.5 EGI BCI and EEG Revenue by Product in 2025
      • 4.10.6 EGI BCI and EEG Revenue by Application in 2025
      • 4.10.7 EGI BCI and EEG Revenue by Geographic Area in 2025
      • 4.10.8 EGI Recent Development
    • 4.11 Blackrock Microsystems LLC
      • 4.11.1 Blackrock Microsystems LLC Company Information
      • 4.11.2 Blackrock Microsystems LLC Description, Business Overview
      • 4.11.3 Blackrock Microsystems LLC BCI and EEG Products Offered
      • 4.11.4 Blackrock Microsystems LLC BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.11.5 Blackrock Microsystems LLC BCI and EEG Revenue by Product in 2025
      • 4.11.6 Blackrock Microsystems LLC BCI and EEG Revenue by Application in 2025
      • 4.11.7 Blackrock Microsystems LLC BCI and EEG Revenue by Geographic Area in 2025
      • 4.11.8 Blackrock Microsystems LLC Recent Development
    • 4.12 Emotiv Inc
      • 4.12.1 Emotiv Inc Company Information
      • 4.12.2 Emotiv Inc Description, Business Overview
      • 4.12.3 Emotiv Inc BCI and EEG Products Offered
      • 4.12.4 Emotiv Inc BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.12.5 Emotiv Inc BCI and EEG Revenue by Product in 2025
      • 4.12.6 Emotiv Inc BCI and EEG Revenue by Application in 2025
      • 4.12.7 Emotiv Inc BCI and EEG Revenue by Geographic Area in 2025
      • 4.12.8 Emotiv Inc Recent Development
    • 4.13 Micromed
      • 4.13.1 Micromed Company Information
      • 4.13.2 Micromed Description, Business Overview
      • 4.13.3 Micromed BCI and EEG Products Offered
      • 4.13.4 Micromed BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.13.5 Micromed BCI and EEG Revenue by Product in 2025
      • 4.13.6 Micromed BCI and EEG Revenue by Application in 2025
      • 4.13.7 Micromed BCI and EEG Revenue by Geographic Area in 2025
      • 4.13.8 Micromed Recent Development
    • 4.14 ANT Neuro B.V
      • 4.14.1 ANT Neuro B.V Company Information
      • 4.14.2 ANT Neuro B.V Description, Business Overview
      • 4.14.3 ANT Neuro B.V BCI and EEG Products Offered
      • 4.14.4 ANT Neuro B.V BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.14.5 ANT Neuro B.V BCI and EEG Revenue by Product in 2025
      • 4.14.6 ANT Neuro B.V BCI and EEG Revenue by Application in 2025
      • 4.14.7 ANT Neuro B.V BCI and EEG Revenue by Geographic Area in 2025
      • 4.14.8 ANT Neuro B.V Recent Development
    • 4.15 Compumedics Limited
      • 4.15.1 Compumedics Limited Company Information
      • 4.15.2 Compumedics Limited Description, Business Overview
      • 4.15.3 Compumedics Limited BCI and EEG Products Offered
      • 4.15.4 Compumedics Limited BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.15.5 Compumedics Limited BCI and EEG Revenue by Product in 2025
      • 4.15.6 Compumedics Limited BCI and EEG Revenue by Application in 2025
      • 4.15.7 Compumedics Limited BCI and EEG Revenue by Geographic Area in 2025
      • 4.15.8 Compumedics Limited Recent Development
    • 4.16 NeuroSky, Inc.
      • 4.16.1 NeuroSky, Inc. Company Information
      • 4.16.2 NeuroSky, Inc. Description, Business Overview
      • 4.16.3 NeuroSky, Inc. BCI and EEG Products Offered
      • 4.16.4 NeuroSky, Inc. BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.16.5 NeuroSky, Inc. BCI and EEG Revenue by Product in 2025
      • 4.16.6 NeuroSky, Inc. BCI and EEG Revenue by Application in 2025
      • 4.16.7 NeuroSky, Inc. BCI and EEG Revenue by Geographic Area in 2025
      • 4.16.8 NeuroSky, Inc. Recent Development
    • 4.17 Artinis Medical Systems BV
      • 4.17.1 Artinis Medical Systems BV Company Information
      • 4.17.2 Artinis Medical Systems BV Description, Business Overview
      • 4.17.3 Artinis Medical Systems BV BCI and EEG Products Offered
      • 4.17.4 Artinis Medical Systems BV BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.17.5 Artinis Medical Systems BV BCI and EEG Revenue by Product in 2025
      • 4.17.6 Artinis Medical Systems BV BCI and EEG Revenue by Application in 2025
      • 4.17.7 Artinis Medical Systems BV BCI and EEG Revenue by Geographic Area in 2025
      • 4.17.8 Artinis Medical Systems BV Recent Development
    • 4.18 Cadwell
      • 4.18.1 Cadwell Company Information
      • 4.18.2 Cadwell Description, Business Overview
      • 4.18.3 Cadwell BCI and EEG Products Offered
      • 4.18.4 Cadwell BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.18.5 Cadwell BCI and EEG Revenue by Product in 2025
      • 4.18.6 Cadwell BCI and EEG Revenue by Application in 2025
      • 4.18.7 Cadwell BCI and EEG Revenue by Geographic Area in 2025
      • 4.18.8 Cadwell Recent Development
    • 4.19 Advanced Brain Monitoring
      • 4.19.1 Advanced Brain Monitoring Company Information
      • 4.19.2 Advanced Brain Monitoring Description, Business Overview
      • 4.19.3 Advanced Brain Monitoring BCI and EEG Products Offered
      • 4.19.4 Advanced Brain Monitoring BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.19.5 Advanced Brain Monitoring BCI and EEG Revenue by Product in 2025
      • 4.19.6 Advanced Brain Monitoring BCI and EEG Revenue by Application in 2025
      • 4.19.7 Advanced Brain Monitoring BCI and EEG Revenue by Geographic Area in 2025
      • 4.19.8 Advanced Brain Monitoring Recent Development
    • 4.20 NCC Medical
      • 4.20.1 NCC Medical Company Information
      • 4.20.2 NCC Medical Description, Business Overview
      • 4.20.3 NCC Medical BCI and EEG Products Offered
      • 4.20.4 NCC Medical BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.20.5 NCC Medical BCI and EEG Revenue by Product in 2025
      • 4.20.6 NCC Medical BCI and EEG Revenue by Application in 2025
      • 4.20.7 NCC Medical BCI and EEG Revenue by Geographic Area in 2025
      • 4.20.8 NCC Medical Recent Development
    • 4.21 SYMTOP
      • 4.21.1 SYMTOP Company Information
      • 4.21.2 SYMTOP Description, Business Overview
      • 4.21.3 SYMTOP BCI and EEG Products Offered
      • 4.21.4 SYMTOP BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.21.5 SYMTOP BCI and EEG Revenue by Product in 2025
      • 4.21.6 SYMTOP BCI and EEG Revenue by Application in 2025
      • 4.21.7 SYMTOP BCI and EEG Revenue by Geographic Area in 2025
      • 4.21.8 SYMTOP Recent Development
    • 4.22 Neuroelectrics
      • 4.22.1 Neuroelectrics Company Information
      • 4.22.2 Neuroelectrics Description, Business Overview
      • 4.22.3 Neuroelectrics BCI and EEG Products Offered
      • 4.22.4 Neuroelectrics BCI and EEG Revenue and Gross Margin (2021-2026)
      • 4.22.5 Neuroelectrics BCI and EEG Revenue by Product in 2025
      • 4.22.6 Neuroelectrics BCI and EEG Revenue by Application in 2025
      • 4.22.7 Neuroelectrics BCI and EEG Revenue by Geographic Area in 2025
      • 4.22.8 Neuroelectrics Recent Development
  • 5 Breakdown Data by Type

    • 5.1 Global BCI and EEG Revenue by Type (2021-2026)
    • 5.2 Global BCI and EEG Revenue Forecast by Type (2027-2032)
    • 5.3 BCI and EEG Revenue Market Share by Type (2021-2032)
  • 6 Breakdown Data by Application

    • 6.1 Global BCI and EEG Revenue by Application (2021-2026)
    • 6.2 Global BCI and EEG Revenue Forecast by Application (2027-2032)
    • 6.3 BCI and EEG Revenue Market Share by Application (2021-2032)
  • 7 North America

    • 7.1 North America BCI and EEG Market Size YoY Growth 2021-2032
    • 7.2 North America BCI and EEG Market Facts & Figures by Country (2021-2032)
    • 7.3 North America BCI and EEG Revenue by Type (2021-2026)
    • 7.4 North America BCI and EEG Revenue by Application (2021-2026)
  • 8 Asia-Pacific

    • 8.1 Asia-Pacific BCI and EEG Market Size YoY Growth 2021-2032
    • 8.2 Asia-Pacific BCI and EEG Market Facts & Figures by Region (2021-2032)
    • 8.3 Asia-Pacific BCI and EEG Revenue by Type (2021-2026)
    • 8.4 Asia-Pacific BCI and EEG Revenue by Application (2021-2026)
  • 9 Europe

    • 9.1 Europe BCI and EEG Market Size YoY Growth 2021-2032
    • 9.2 Europe BCI and EEG Market Facts & Figures by Country (2021-2032)
    • 9.3 Europe BCI and EEG Revenue by Type (2021-2026)
    • 9.4 Europe BCI and EEG Revenue by Application (2021-2026)
  • 10 Latin America

    • 10.1 Latin America BCI and EEG Market Size YoY Growth 2021-2032
    • 10.2 Latin America BCI and EEG Market Facts & Figures by Country (2021-2032)
    • 10.3 Latin America BCI and EEG Revenue by Type (2021-2026)
    • 10.4 Latin America BCI and EEG Revenue by Application (2021-2026)
  • 11 Middle East and Africa

    • 11.1 Middle East and Africa BCI and EEG Market Size YoY Growth 2021-2032
    • 11.2 Middle East and Africa BCI and EEG Market Facts & Figures by Country (2021-2032)
    • 11.3 Middle East and Africa BCI and EEG Revenue by Type (2021-2026)
    • 11.4 Middle East and Africa BCI and EEG Revenue by Application (2021-2026)
  • 12 Supply Chain and Sales Channel Analysis

    • 12.1 BCI and EEG Supply Chain Analysis
    • 12.2 BCI and EEG Key Raw Materials and Upstream Suppliers
    • 12.3 BCI and EEG Clients Analysis
    • 12.4 BCI and EEG Sales Channel and Sales Model Analysis
      • 12.4.1 BCI and EEG Distribution Channel Analysis: Indirect Sales VS Direct Sales
      • 12.4.2 BCI and EEG Distribution Channel Analysis: Online Sales VS Offline Sales
      • 12.4.3 BCI and EEG Distributors
  • 13 Market Dynamics

    • 13.1 BCI and EEG Industry Trends
    • 13.2 BCI and EEG Market Drivers
    • 13.3 BCI and EEG Market Challenges
    • 13.4 BCI and EEG Market Restraints
  • 14 Research Findings and Conclusion

  • 15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details
    • 15.3 Disclaimer
USD 5,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.